Daily as of 3 Nov 16:00 ET
- Price
- above both $9.95 vs 50 $9.92 / 200 $7.53
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 4 Jun 2026 · projected 27 bars out · tested 7 bars
SGMT | Sagimet Biosciences Inc. Series ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.95
+$0.26 (+2.68%)
Sagimet Biosciences Inc. Series A (SGMT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- above both $9.94 vs 50 $9.27 / 200 $8.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 4 Jun 2026 | 🟨Golden moderate | daily | 27 bars out | 7 bar cross test |
| 22 Jan 2026 | 💀Death steep | daily | 27 bars out | 2 bar cross test |
| 25 Jun 2025 | 🟨Golden steep | daily | 27 bars out | Not tested |
| 21 Mar 2025 | 💀Death moderate | daily | 14 bars out | 1 bar cross test |
| 15 Nov 2024 | 🟨Golden | daily | 18 bars out | 5 bar cross test |
About SGMT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$11.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandsmall